Clinical Trial Registry

AMERICAS

Study Name Institution/Hospital Principal Investigator

Further Information

A Randomized Phase II Study of Systemic Chemotherapy with or without HAI FUDR-Dexamethasone in Patients with Unresectable Intrahepatic Cholangiocarcinoma

Memorial Sloan Kettering Cancer Center,

New York, USA.

Dr. William Jarnagin. Please see Clinical Trial Information here

 

EUROPE, AFRICA AND MIDDLE EAST

Study Name Institution/Hospital Principal Investigator Further Information
NELMAS: phase II study comparing adjuvant treatment with 177Lu-DOTATATE (Lutathera®) to best support care in patients after resection of neuroendocrine liver metastases

Imperial College London

London, UK. 

Professor Andrea Frilling. Please see Clinical Trial Information here

 

If you would like to add details of an HPB Clinical Trial to the IHPBA registry please complete the form below.

Submit clinical trial details here

All submissions will be reviewed by the IHPBA Research Committee before being added to the website.  

Corporate Partners

Angiodynamics logo
Baxter logo

If you are interested in becoming a Corporate Partner of the IHBPA please contact industry@ihpba.org

Find out more